Bassel K, Lee M, Seymour N E
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
South Med J. 1994 Sep;87(9):918-20. doi: 10.1097/00007611-199409000-00011.
The management of focal nodular hyperplasia (FNH) of the liver requires a systematic approach. After a histologic diagnosis of FNH is obtained, asymptomatic lesions can be observed safely with regular follow-up and treated if they become symptomatic or enlargement occurs. In the case presented here, we have elected follow-up with serial CT scans because our patient is asymptomatic and the lesion has not significantly enlarged. Patients who have symptomatic lesions while taking an oral contraceptive can have conservative follow-up when they stop taking the oral contraceptive, because regression of FNH has been reported to occur after cessation of oral contraceptive use. If the patient remains symptomatic or if the lesion enlarges after discontinuance of oral contraceptive use, surgical resection is warranted. Other symptomatic patients, including those with a previous history of taking oral contraceptives, should be treated by surgical resection or, when resection is not possible, by embolization or ligation of the hepatic artery, because symptomatic patients are at risk for having malignant lesions misdiagnosed as FNH.
肝脏局灶性结节性增生(FNH)的管理需要一种系统的方法。在获得FNH的组织学诊断后,无症状的病变可通过定期随访安全观察,若出现症状或病变增大则进行治疗。在此病例中,我们选择通过系列CT扫描进行随访,因为我们的患者无症状且病变未显著增大。服用口服避孕药时出现症状性病变的患者,在停止服用口服避孕药后可进行保守随访,因为有报道称停用口服避孕药后FNH会消退。如果患者仍有症状,或者在停用口服避孕药后病变增大,则有必要进行手术切除。其他有症状的患者,包括有口服避孕药史的患者,应接受手术切除治疗,或者在无法进行切除时,通过肝动脉栓塞或结扎进行治疗,因为有症状的患者存在将恶性病变误诊为FNH的风险。